Peugeot S.A. (Paris:UG) ("Groupe PSA”) launches today the sale of 9,663,000 Faurecia shares, representing approximately 7% of Faurecia’s share capital, further to the press release published by Groupe PSA earlier today relating to the merger process between Fiat Chrysler Automobiles N.V. ("FCA”) and Groupe PSA.
The transaction will be conducted via an institutional private placement by way of an accelerated bookbuilding.
The bookbuilding will start immediately; the results of the placement will be announced after the close of the bookbuilding process.
The cash proceeds from this contemplated disposal are expected to be distributed to the Stellantis shareholders along with the distribution in kind of the remaining c. 39% stake in Faurecia, as already announced on 14th September 2020, promptly after the completion of the merger and subject to approval by the Stellantis Board and shareholders.
Groupe PSA has granted to the Bookrunners a 90-day lock-up, subject to certain usual exceptions (including the aforementionned distribution in kind).
The final terms of the Placement are expected to be announced on October 29, 2020 at the latest. The settlement and delivery of such sale is expected to occur on November 2, 2020.
Faurecia shares are listed on the regulated market of Euronext Paris (ISIN FR0000121147).
This press release does not constitute an offer to sell or a solicitation to buy any securities, and the offer of Faurecia shares by Groupe PSA does not constitute a public offering.
About Groupe PSA
Groupe PSA designs unique automotive experiences and delivers mobility solutions to meet all customer expectations. The Group has five car brands, Peugeot, Citroën, DS, Opel and Vauxhall and provides a wide array of mobility and smart services under the Free2Move brand. Its ‘Push to Pass’ strategic plan represents a first step towards the achievement of the Group’s vision to be "a global carmaker with cutting-edge efficiency and a leading mobility provider sustaining lifetime customer relationships”. An early innovator in the field of autonomous and connected cars, Groupe PSA is also involved in financing activities through Banque PSA Finance and in automotive equipment via Faurecia.
Media library: medialibrary.groupe-psa.com / @GroupePSA_EN
This announcement is for information purposes only and does not constitute an offer to sell or a solicitation to buy any securities, and the offer of Faurecia shares by Groupe PSA does not constitute a public offering in any jurisdiction, including in France.
This communication is for distribution in the United Kingdom only to (i) investment professionals falling within article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") or (ii) high net worth entities and other persons to whom it may lawfully be communicated, falling within article 49(2)(a) to (d) of the Order (all such persons together being referred to as "relevant persons").
The offer and sale of the securities referred to in this announcement has not been, nor will be, registered under the United States Securities Act of 1933 (the "Securities Act") and the securities may not be offered or sold in the United States absent such registration or an applicable exemption from the registration requirements of the Securities Act. There will be no public offering of the securities in the United States in connection with this transaction.
Any investment decision to buy shares in Faurecia must be made solely on the basis of publicly available information regarding Faurecia. Such information is not the responsibility of Groupe PSA.
Release, publication or distribution of this press release is forbidden in any country where it would violate applicable laws or regulations. This press release may not be published, forwarded or distributed, directly or indirectly, in the United States, Canada, Australia or Japan.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201028006057/en/
WASHINGTON, Oct. 25, 2020 /PRNewswire/ -- In response to President Trump's baseless claims about physicians miscounting deaths due to COVID-19, the American College of Emergency Physicians (ACEP) released the following statement:
"On behalf of the nation's emergency physicians, ACEP is appalled by President Trump's reckless and false assertions that physicians are overcounting deaths related to COVID-19. Emergency physicians and other health care workers have risked their lives day in and day out for almost a year battling the greatest public health crisis in a generation—all while watching countless patients die alone, going to work without sufficient protection equipment, and struggling with crushing anxiety about getting sick or spreading the virus to their loved ones.
To imply that emergency physicians would inflate the number of deaths from this pandemic to gain financially is offensive, especially as many are actually under unprecedented financial strain as they continue to bear the brunt of COVID-19. These baseless claims not only do a disservice to our health care heroes but promulgate the dangerous wave of misinformation which continues to hinder our nation's efforts to get the pandemic under control and allow our nation to return to normalcy."
The American College of Emergency Physicians (ACEP) is the national medical society representing emergency medicine. Through continuing education, research, public education, and advocacy, ACEP advances emergency care on behalf of its 40,000 emergency physician members, and the more than 150 million Americans they treat on an annual basis. For more information, visit www.acep.org and www.emergencyphysicians.org.
View original content to download multimedia:https://www.prnewswire.com/news-releases/acep-rebuts-president-trumps-false-statements-about-overcounting-covid-19-deaths-301159182.html
SOURCE American College of Emergency Physicians (ACEP)
Travel nurses and allied professionals nationwide can now download the most powerful and practical mobile app to help them find, book, and manage their assignments with the launch of newest version of AMN Passport by AMN Healthcare (NYSE: AMN).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200826005668/en/
Travel nurses and allied professionals nationwide can now download the most powerful and practical mobile app to help them find, book, and manage their assignments with the launch of newest version of AMN Passport by AMN Healthcare. (Photo: Business Wire)
Now available in the Apple App Store and the Google Play Store, AMN Passport provides clinicians with the healthcare industry’s easiest-to-use and most comprehensive application for their mobile devices.
The app provides a personalized experience that encompasses all information travel clinicians need to successfully manage their careers. AMN Passport customizes job preferences, manages and updates credentials and professional profiles, accesses time and pay details, provides alerts and updates without clogging up email, shows exactly where clinicians are in the onboarding process, and contacts dedicated recruiters with one tap. With AMN Passport, clinicians can now put their career in their pocket.
"AMN Healthcare is committed to providing the best possible experience for our clinicians, and that’s why we will continuously improve AMN Passport so they can maximize the professional and personal experience of their assignments,” said Landry Seedig, Group President and Chief Operating Officer, Nursing and Allied Solutions, at AMN Healthcare. "Nurses and allied health professionals can now go from accepting a contract to confirming their paycheck with complete confidence on a mobile device – and with convenience and seamless experience that nobody else can offer.”
AMN Healthcare is the leader and innovator in healthcare total talent services, providing healthcare organizations across the nation with the most advanced and comprehensive array of technology-enabled solutions. To learn more about how AMN Passport puts you at the helm of your experience, go to https://www.amnpassport.com.
About AMN Healthcare?
AMN Healthcare is the leader and innovator in total talent solutions for healthcare organizations across the nation. The Company provides access to the most comprehensive network of quality healthcare professionals through its innovative recruitment strategies and breadth of career opportunities. With insights and expertise, AMN Healthcare helps providers optimize their workforce to successfully reduce complexity, increase efficiency and improve patient outcomes. AMN total talent solutions include managed services programs, clinical and interim healthcare leaders, temporary staffing, executive search solutions, vendor management systems, recruitment process outsourcing, predictive modeling, language interpretation services, revenue cycle solutions,?credentialing?and other services. Clients include acute-care hospitals, community health centers and clinics, physician practice groups, retail and urgent care centers, home health facilities, schools and many other healthcare settings. AMN Healthcare is committed to fostering and maintaining a diverse team that reflects the communities we serve. Our commitment to the inclusion of many different backgrounds, experiences and perspectives enables our innovation and leadership in the healthcare services industry. For more information about AMN Healthcare, visit?www.amnhealthcare.com.?
View source version on businesswire.com: https://www.businesswire.com/news/home/20200826005668/en/